tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Howard Liang, 4 are a BUY (66.67%), 2 are a HOLD (33.33%).
Analyst Howard Liang, carries an average stock price target met ratio of 100% that have a potential upside of 47.72% achieved within 1099 days. Previously, Howard Liang worked at LEERINK.
Howard Liang’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 22-Apr-2015.
Analyst best performing recommendations are on AMGN (AMGEN).
The best stock recommendation documented was for AMGN (AMGEN) at 10/2/2013. The price target of $128 was fulfilled within 393 days with a profit of $39.47 (44.58%) receiving and performance score of 1.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$280
$14.14 (5.32%)
$235
5 days ago
(07-May-2025)
16/21 (76.19%)
$4.16 (1.51%)
430
Buy
$320
$54.14 (20.36%)
$324
10 days ago
(02-May-2025)
12/16 (75%)
$38.78 (13.79%)
75
Hold
$330
$64.14 (24.13%)
$303
1 months 3 days ago
(09-Apr-2025)
13/14 (92.86%)
$38.91 (13.37%)
730
Sell
$294
$28.14 (10.58%)
$275
2 months 7 days ago
(04-Mar-2025)
4/5 (80%)
$-18.19 (-5.83%)
89
Buy
$329
$63.14 (23.75%)
$310
3 months 2 days ago
(09-Feb-2025)
1/2 (50%)
$34.21 (11.60%)
54
What Year was the first public recommendation made by Howard Liang?
